Seeking Alpha

Healthcare upgrades and initiations for Friday

  • Amarin (AMRN) upgraded to Buy from Neutral at Citi. Price target unchanged at $2.50.
  • Salix Pharmaceuticals (SLXP) upgraded to Buy from Neutral at Janney. Price target hiked to $95 from $60. See: SLXP in deal for SNTS.
  • Tenet Healthcare (THC) initiated at Market Perform at FBR. Price target is $49.
  • Universal Health Services (UHS) initiated at Outperform at FBR. Price target is $94.
  • Quest Diagnostics (DGX) initiated at Market Perform at FBR. Price target is $68.
  • HCA Holdings (HCA) initiated at Outperform at FBR. Price target is $53.
  • Lifepoint (LPNT) initiated at Market Perform at FBR. Price target is $55.
Comments (1)
  • 2puttwo
    , contributor
    Comments (390) | Send Message
     
    I wonder what Citi knows about the FDA that us little guys don't have a clue about knowing. Talk about being taken to the woodshed. First good day with Amarin this year, and Citi rides to the rescue on their white horse. Great call. Those Citi analyst's, really know how to pick the bottom. Duhhhhhhh!
    8 Nov 2013, 06:18 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|